<DOC>
	<DOC>NCT00768742</DOC>
	<brief_summary>The primary objective of this study is to test the hypothesis that a minimum 75% volume radiofrequency ablation of fibroids associated with menorrhagia results in reduction of menstrual bleeding.</brief_summary>
	<brief_title>Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>Premenopausal Regular, consistent menstrual cycles Serum progesterone &gt; 6 ng/ml (19 nmol/L) 2 months history of PBLAC score of 150500 Maximum of 4 type I, type II, or intramural fibroids Patient is at low risk for cervical cancer Hemoglobin &gt; 6 g/dl Not at risk for pregnancy No desire for future fertility Willing and able to complete the followup requirements outlined in the study design section of the protocol Willing to sign a consent form Subserosal fibroids. Any fibroid that obstructs access to the endometrial cavity FSH &gt; 20 IU/L Pregnancy Evidence of disorders of hemostasis Use of GnRH agonist or depomedroxyprogesterone acetate or other implantable or injectable progestin and/or estrogen SERMS/SPRMS within the last 6 months Current use of any IUD or use of Mirena IUS within the last 3 months Gynecological malignancy or hyperplasia Known/suspected abdominal/pelvic cancer Active pelvic infection (e.g., active salpingitis or other pelvic inflammatory disease) Adenomyosis Previous surgical or ablative treatment for fibroids or menorrhagia Previous uterine artery embolization or occlusion Patient on anticoagulation therapy Needing emergency surgery to treat fibroid symptoms Concomitant intrauterine polyps. Major medical or psychiatric illness affecting general health or patient's ability to comply with followup schedule or provide valid patient selfassessment data Contraindication to MRI Allergy to contrast media Mild renal insufficiency or worse Known renal disease Uncontrolled hypertension lasting 2 years or more Diabetes Uterine size &gt; 10 weeks or 10 cm from ectocervix to fundus.</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Uterine Fibroid RF Ablation</keyword>
	<keyword>Intrauterine Ultrasound</keyword>
	<keyword>VizAblate</keyword>
</DOC>